QNRX Stock Analysis: Buy, Sell, or Hold?
QNRX - Quoin Pharmaceuticals, Ltd. American Depositary Shares
$5.57
0.58 (11.62%)
▲
5d:
+9.43%
30d:
+27.46%
90d:
+14.85%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When QNRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: QNRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: QNRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: QNRX is currently trading at $5.57, which is considered extended relative to its 30-day fair value range of $4.17 to $5.25.
Technical Outlook: Technically, QNRX is in a downtrend. Immediate support is located at $4.55, while resistance sits at $6.38. The stock is showing strong short-term momentum, up 11.6% recently.
Market Sentiment: QNRX scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.40 (+330.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QNRX is in a downtrend. Immediate support is located at $4.55, while resistance sits at $6.38. The stock is showing strong short-term momentum, up 11.6% recently.
Market Sentiment: QNRX scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.40 (+330.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.17 -
$5.25
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.6%)
- BULLISH: Trading 330.6% below Wall St target ($21.40)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.17 -
$5.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.55
Resistance Level
$6.38
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.56
Wall Street Target
$21.40
(+330.6%)
Share & Embed Analysis
Last updated: August 24, 2026 6:54 AM ET
Data refreshes hourly during market hours. Next update: 7:54 AM
Data refreshes hourly during market hours. Next update: 7:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
